Related Experiment Videos
Mecamylamine-precipitated nicotine-withdrawal aversion in rats
1Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan.
European Journal of Pharmacology
|October 31, 1996
Summary
This study developed a quick rat model for nicotine dependence. Mecamylamine triggered withdrawal aversion in nicotine-dependent rats, indicating physical dependence and offering a new research tool.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Nicotine dependence is a significant public health issue.
- Developing reliable models to study nicotine dependence is crucial for therapeutic advancements.
Purpose of the Study:
- To establish a rapid and convenient animal model for evaluating nicotine dependence.
- To investigate the role of physical dependence in nicotine withdrawal using the conditioned place preference paradigm.
Main Methods:
- Chronic subcutaneous nicotine infusion (9 mg/kg/day) in rats for 7 days using osmotic minipumps.
- Administration of the nicotinic receptor antagonist mecamylamine.
- Assessment of place aversion in a conditioned place preference paradigm.
Main Results:
- Nicotine-dependent rats exhibited a place aversion when treated with mecamylamine.
- No place aversion was observed in rats receiving acute nicotine or in sham-operated controls.
- Mecamylamine-precipitated withdrawal aversion suggests physical nicotine dependence.
Conclusions:
- The conditioned place preference paradigm with mecamylamine-induced aversion is a viable model for studying nicotine physical dependence.
- This model offers a rapid and convenient method for evaluating nicotine dependence in research settings.